Article
Genome editing in mammalian cells using the CRISPR type I-D nuclease.
Nucleic acids research - 21 Jun 2021
Osakabe Keishi, Wada Naoki, Murakami Emi, Miyashita Naoyuki, Osakabe Yuriko
Abstract excerpt
Adoption of CRISPR-Cas systems, such as CRISPR-Cas9 and CRISPR-Cas12a, has revolutionized genome engineering in recent years; however, application of genome editing with CRISPR type I-the most abundant CRISPR system in bacteria-remains less developed. Type I systems, such as type I-E, and I-F, comprise the CRISPR-associated complex for antiviral defense ('Cascade': Cas5, Cas6, Cas7, Cas8 and the small subunit)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
